Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Fuchs Henry J
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   222,228    

Indirect Shares

   0      
Direct Value   $18,063,061    

Indirect Value

   $0      
Total Shares   222,228      
Total Value   $18,063,061      


Onyx Pharmaceuticals Inc $0 Biomarin Pharmaceutical Inc $17,448,765 Mirati Therapeutics, Inc. $614,296 Onyx Pharmaceuticals Inc $0 Biomarin Pharmaceutical Inc $17,448,765 Mirati Therapeutics, Inc. $614,296
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Onyx Pharmaceuticals Inc ONXX EVP & Chief Medical Of... 2008-11-18 14,891 2006-05-15 0    Premium*  
            Ardea Biosciences Inc RDEA Director 2012-06-19 0 2007-12-05 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN President, Worldwide R&D 2024-03-15 196,872 2009-03-02 0    Premium*  
            Genomic Health Inc GHDX Director 2019-11-08 0 2014-04-01 0    Premium*  
            Mirati Therapeutics, Inc. MRTX 2023-01-20 10,465 2020-01-03 0    Premium*  
* Premium Members only  

Records found :    294         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 11 of 12
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2013-09-05 4 AS $70.00 $700,000 D/D (10,000) 43,266 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2013-05-22 4 AS $65.66 $781,240 D/D (11,899) 53,074 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-04-02 4 AS $80.12 $801,200 D/D (10,000) 156,676 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2013-09-19 4 AS $80.19 $801,900 D/D (10,000) 43,266 0 -
GHDX Genomic Health Inc Director   –       •      –    2019-02-22 4 OE $27.75 $853,192 D/D 26,479 32,811 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2015-03-16 4 OE $21.51 $860,400 D/D 40,000 129,950 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2020-03-13 4 D $84.50 $886,912 D/D (10,496) 127,485 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2019-03-15 4 D $94.53 $892,647 D/D (9,443) 133,061 0 -
RDEA Ardea Biosciences Inc Director   –       •      –    2007-12-04 4 S $10.78 $895,794 D/D (83,107) 0 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Medical Officer   •       –      –    2008-05-29 4 S $35.90 $897,663 D/D (25,000) 16,975 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2019-03-18 4 AS $94.09 $902,982 D/D (9,597) 136,304 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Medical Officer   •       –      –    2008-05-16 4 AS $35.80 $936,311 D/D (26,041) 16,975 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2022-03-15 4 D $78.27 $947,145 D/D (12,101) 146,012 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Medical Officer   •       –      –    2007-08-30 4 S $38.19 $956,260 D/D (25,000) 17,292 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Medical Officer   •       –      –    2008-08-14 4 S $40.94 $1,050,139 D/D (25,000) 16,975 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-06-14 4 OE $21.51 $1,067,380 D/D 31,000 175,848 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2023-08-10 4 S $90.43 $1,085,111 D/D (12,000) 176,187 0 -
MRTX Mirati Therapeutics, Inc.   –       •      –    2022-02-11 4 AS $104.76 $1,161,717 D/D (11,000) 6,021 0 %
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-08-24 4 S $99.00 $1,237,500 D/D (12,500) 142,667 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-08-27 4 S $100.00 $1,250,000 D/D (12,500) 130,167 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2013-04-30 4 S $63.29 $1,265,800 D/D (20,000) 44,589 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-06-16 4 AS $90.00 $1,295,730 D/D (14,397) 136,422 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2016-11-25 4 AS $87.40 $1,310,988 D/D (15,000) 113,878 0 -
MRTX Mirati Therapeutics, Inc.   –       •      –    2020-08-10 4 AS $127.52 $1,313,783 D/D (10,000) 2,000 0 %
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-05-26 4 S $87.34 $1,317,100 D/D (15,000) 115,914 0 -
  294  Records found
  1   2   3   4   5   6   7   8   9   10   11  12      
  Page 11 of 12  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us